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Short Communication
Tentative Colistin Epidemiological Cut-Off Value
for Salmonella spp.
Yvonne Agersø,1 Mia Torpdahl,2 Camilla Zachariasen,2 AnneMette Seyfarth,1
Anette M. Hammerum,2 and Eva Møller Nielsen2
Abstract
The objective of this research was to determine minimal inhibitory concentration (MIC) population distributions
for colistin for Salmonella on subtype level. Furthermore, we wanted to determine if differences in MIC for
colistin could be explained by mutations in pmrA or pmrB encoding proteins involved in processes that influence
the binding of colistin to the cell membrane. During 2008–2011, 6,583 Salmonella enterica subsp. enterica isolates of
human origin and 1931 isolates of animal/meat origin were collected. The isolates were serotyped, and sus-
ceptibility was tested towards colistin (range 1–16mg/L). Moreover, 37 isolates were tested for mutations in
pmrA and pmrB by polymerase chain reaction (PCR) and DNA sequencing. MIC distribution for colistin at
serotype level showed that Salmonella Dublin (n= 198) followed by Salmonella Enteritidis (n= 1247) were less
susceptible than ‘‘other’’ Salmonella serotypes originating from humans (n= 5,274) and Salmonella Typhimurium
of animal/meat origin (n = 1794). MIC was £ 1mg/L for 98.9% of ‘‘other’’ Salmonella serotypes originating from
humans, 99.4% of Salmonella Typhimurium, 61.3% of Salmonella Enteritidis, and 12.1% of Salmonella Dublin
isolates. Interestingly, Salmonella Dublin and Salmonella Enteritidis belong to the same O-group (O:1, 9,12),
suggesting that surface lipopolysaccharides (LPS) of the cell (O-antigen) play a role in colistin susceptibility. The
epidemiological cut-off value of > 2mg/L for colistin suggested by European Committee on Antimicrobial
Susceptibility Testing (EUCAST) is placed inside the distribution for both Salmonella Dublin and Salmonella
Enteritidis. All tested Salmonella Dublin isolates, regardless of MIC colistin value, had identical pmrA and pmrB
sequences. Missense mutations were found only in pmrA in one Salmonella Reading and in pmrB in one Salmonella
Concord isolate, both with MIC of £ 1 for colistin. In conclusion, our study indicates that missense mutations are
not necessarily involved in increased MICs for colistin. Increased MICs for colistin seemed to be linked to specific
serotypes (Salmonella Dublin and Salmonella Enteritidis). We recommend that Salmonella with MIC of > 2mg/L
for colistin be evaluated on the serovar level.
Introduction
The interpretive criteria are crucial when determiningbacteria as either resistant or sensitive to an antimicrobial
drug. The European Committee on Antimicrobial Suscept-
ibility Testing (EUCAST, 2011) presents a clinical breakpoint
and an epidemiological cut-off value of > 2mg/L for colistin,
based on a few isolates, whereas Salmonella isolates with a
Minimal Inhibitory Concentration (MIC) of £ 2mg/L should
be reported as sensitive or wildtype. Clinical Laboratory
Standards Institute (CLSI) defines clinical breakpoints in-
cluding also treatment efficacy (CLSI, 2011). The epidemio-
logical cut-off value is defined based on MIC population
distributions of Salmonella spp. (EUCAST, 2011).
Previously, colistin was used less frequently due to toxicity,
but recently it has become the first choice treatment of severe
infections involving some multidrug resistant Gram-negative
bacteria (Lim et al., 2010).
We hypothesized that colistin MIC population distribu-
tions of Salmonella on serotype level differ andMICs of colistin
are increased in Salmonella isolates withmissensemutations in
pmrA or pmrB encoding products involved in processes that
influence cell membrane binding of colistin (Roland et al.,
1993; Sun et al., 2009).
The objective of this work was to determine MIC popula-
tion distributions for Salmonella on subtype level and to de-
termine if differences inMIC could be explained bymutations
in pmrA or pmrB.
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Methods
From 2008 to 2011, the MIC for colistin (concentration
range 1–16mg/L) was determined using commercially de-
hydrated antimicrobial agents in microtiter wells (Sensiti-
treTM; TREK Diagnostic Systems Ltd., West Sussex, United
Kingdom) as part of the Danish Integrated Antimicrobial
Resistance Monitoring and Research Programme (DANMAP)
(CLSI, 2008; DANMAP, 2008–2010). From human patients in
Denmark, 6,583 Salmonella enterica subsp. enterica isolates
were tested. Among these isolates, the most common sero-
types were Salmonella Typhimurium (3,281 isolates, including
monophasic variants S. 4,5,12:i:- and S. 4,12:i:-), Salmonella
Enteritidis (1,178 isolates), and Salmonella Dublin (131 iso-
lates). The remaining 1,993 isolates belonged to 198 different
serotypes. Furthermore, 1,795 Salmonella Typhimurium, 69
Salmonella Enteritidis, and 67 Salmonella Dublin from food
animals and raw meat were tested.
In order to determine if differences in MIC were caused by
mutations in pmrA and pmrB, we looked for mutations in 37
isolates (with MIC and identification verified) of serovar Sal-
monella Dublin (n= 22), Salmonella Enteritidis (n = 14), and
Salmonella Typhimurium (n = 1) from human infections in
2009 with MIC values of 2, 4, or 8mg/L. In addition, one
isolate of each of the above-mentioned three serotypes, plus
one SalmonellaConcord and one Salmonella Reading withMIC
of £ 1 were included to look for differences in susceptible
isolates of five different serotypes. The pmrA and pmrB genes
were sequenced using the primers reported by Sun et al. (2009)
and additional new primers designed to fully include pmrB
(forward: 5¢-CGACGGACTCAATCTCAAG-3¢; reverse: 5¢-
GCATATACATAATTTGCGCGA-3¢).
Results and Discussion
The MIC distribution for all Salmonella isolates is shown in
Figure 1A; the MIC distributions for Salmonella Dublin, Sal-
monella Enteritidis, Salmonella Typhimurium (food animals and
raw meats), and ‘‘other’’ serotypes originating from humans
are presented in Figure 1B. Salmonella Dublin followed by
Salmonella Enteritidis were less susceptible than the other Sal-
monella serotypes. Interestingly, Salmonella Dublin and Salmo-
nella Enteritidis have the same O-antigen formula (O:1, 9,12).
Therefore, we also looked at theMIC distribution of colistin
for available SalmonellaNapoli (n= 18) and Salmonella Panama
(n = 30), which also have this O-antigen formula. Although
these two serovars also seemed less susceptible to colistin
than Salmonella in general, the trend was not as pronounced;
MIC was £ 1mg/L for 98.9% of ‘‘other’’ Salmonella serotypes
of human origin, 99.4% for Salmonella Typhimurium from
animal/meat origin, 89% for Salmonella Napoli, 80% for Sal-
monella Panama, 61.3% for Salmonella Enteritidis, and 12.1%
for Salmonella Dublin. This suggests that the surface lipo-
polysaccharides (LPS) of the cell (O-antigen) play a role in
colistin susceptibility. The epidemiological cut-off value sug-
gested by EUCAST ( > 2mg/L) is placed inside the distribu-
tion for both SalmonellaDublin and Salmonella Enteritidis. Due
to the low number of especially Salmonella Dublin when
compared to other Salmonella, these differences related to se-
rotypes are overlooked when merging all Salmonella into the
same distribution (Fig. 1).
Colistin targets the cell envelope, and the interaction be-
tween the cationic polypeptide and negatively charged LPS
leads to a disturbance of the outer membrane and a subse-
quent increase in the permeability of the cell envelope re-
sulting in death (Schindler and Osborn, 1979; Sun et al., 2009).
Increase in MIC for Salmonella Typhimurium has been map-
ped to pmrA and pmrB, which constitute a two-component
regulatory system. PmrB is a sensor histidine kinase, and
PmrA is the cognate response regulator. The modifications in
these genes influence the regulation of proteins, which makes
the LPS less negatively charged and thereby decrease the
binding of colistin (Roland et al., 1993; Sun et al., 2009).
Sun et al. (2009) found 27 missense mutations in pmrB and
pmrA that lead to an increasedMIC to colistin of up to 4.4mg/
L. For the isolates tested in the present study, all Salmonella
Dublin isolates, regardless of the MIC value, had identical
pmrA and pmrB sequences. Compared to the Salmonella LT2
strain (GenBank accession no. NC003197), the Salmonella
Dublin isolates had a point mutation in pmrB position 25 (A/
C), leading to an amino acid change in position 9 from thre-
onine to proline. None of the other isolates had this mutation.
In addition, five and six synonymous point mutations were
seen in pmrB Salmonella Dublin and Salmonella Enteritidis
isolates, respectively (two of them were identical, positions
492 and 750). No missense mutation was present in pmrA, but
synonymous point mutations were seen at positions 177 and
322 in Salmonella Dublin (C/T) and at positions 322 and 414
in Salmonella Enteritidis (C/T). In addition, missense
FIG. 1. (A) Percentage distribution of minimal inhibitory
concentration (MIC) of colistin determined for all Salmonella
serovars analyzed (n = 8,514). (B)MIC distribution of ‘‘other’’
Salmonella serovars from humans (n = 5,274), Salmonella
Typhimurium from food animals and raw meats (n = 1,795),
Salmonella Enteritidis (n = 1,247), and Salmonella Dublin
(n= 198).
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mutations in pmrA were found in one Salmonella Reading
isolate, and a missense mutation in pmrB was found in one
Salmonella Concord isolate; both had MIC of £ 1. Therefore,
missense mutations are not necessarily involved in increased
MICs for colistin.
In conclusion, since increased MIC seemed linked to sero-
type, we recommend that isolates with MIC of > 2mg/L for
colistin in Salmonella spp. be evaluated on the serotype level.
More detailed data when making population distributions
(such as interpreting results based on the subtype level and
looking for resistance mechanisms) may be necessary when
determining interpretive criteria.
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